About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in New York | 196 Studies

Clinical Trials Prostate CancerNew York

Prostate Cancer Clinical Trials in New York

Find 196 clinical trials for prostate cancer near New York, New York. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 21-40 of 196 trials

Active not recruitingRadiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE TrialThis phase II trial studies how well radiation therapy with or without apalutamide works in treating patients with prostate cancer that has come back (recurrent).NCT03371719·Gilbert, Arizona and 359 others

Prostate Cancer Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedRadioimmunotherapy in Prostate Cancer Using 177Lu-J591 AntibodyThe purpose of this study is to test the safety of the experimental drug, 177Lu-J591 and see what effects (good and bad) it has on your prostate cancer.NCT00538668·New York, New York

CompletedPhase II Sunitinib Prog Met AIPCThe purpose of this research study is to find out what effects (good and bad) Sutent has on you and your prostate cancer.NCT00599313·Phoenix, Arizona and 44 others

CompletedStudy of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate CancerThe purpose of this trial is to confirm a safe dose of AS1404, to be given with docetaxel, and to see whether adding AS1404 and docetaxel together improves the outcome of the…NCT00111618·Alhambra, California and 26 others

CompletedAndrogen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen ablation therapy may stop the adrenal glands from making androgens.NCT00309985·Anchorage, Alaska and 342 others

CompletedA Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerThis is a randomized, open-label, three-arm, phase 3 study in men with biochemically recurrent prostate cancer and PSA doubling time ≤ 9 months at the time of study entry.NCT03009981·Phoenix, Arizona and 68 others

CompletedA Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate CancerThis is an open-label study comparing the imaging characteristics of 123-I-MIP-1072 and ProstaScint® (111-In-capromab pendetide)in patients with metastatic prostate cancer.NCT00992745·Laguna Niguel, California and 6 others

Active not recruitingSurgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00430183·Anchorage, Alaska and 225 others

CompletedRetrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)Dosimetry efficacy of the hydrogel spacer.NCT05423431·Lake Success, New York

CompletedHormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Hormones can stimulate the growth of prostate cancer cells. Hormone therapy may fight prostate cancer by reducing the production of androgens.NCT00005044·Birmingham, Alabama and 260 others

CompletedPET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted BiopsyThe principal aim of this study is to determine if PET/MRI imaging with 18-F fluciclovine (Axumin) identifies those men with false negative MRI fusion targeted biopsy (MRFTB) of…NCT03635866·New York, New York

CompletedRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002597·Birmingham, Alabama and 238 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

RecruitingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)The Phase 2 monotherapy portion of this study is currently enrolling and will evaluate the efficacy and safety of PC14586 (INN rezatapopt) in participants with locally advanced or…NCT04585750·Irvine, California and 75 others

CompletedA Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate CancerThis is a randomized, open-label study designed to assess the effects of sipuleucel-T when administered concurrently or sequentially with enzalutamide.NCT01981122·Tucson, Arizona and 18 others

CompletedS0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Androgens can stimulate the growth of prostate cancer cells.NCT00028769·Mobile, Alabama and 90 others

CompletedAdenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerThis is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with…NCT04381832·Cerritos, California and 18 others

CompletedRadiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerRATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an effective treatment for prostate cancer.NCT00002602·Birmingham, Alabama and 227 others

CompletedPROCLAIM: Germline Genetic Testing for Prostate Cancer PatientsThis registry is for men who have prostate cancer and have had multigene panel hereditary testing.NCT05447637·San Diego, California and 18 others

TerminatedSafety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory MalignanciesThis study will test the safety, tolerance, and efficacy of different doses of oral gallium maltolate.NCT00050687·Springdale, Arkansas and 4 others

PreviousPage 2 of 10Next

Other Conditions in New York

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma